本页面由Tiger Trade Technology Pte. Ltd.提供服务

Arcutis Biotherapeutics Inc.

23.78
-1.0900-4.38%
盘后23.74-0.0400-0.17%19:37 EDT
成交量:153.60万
成交额:3,681.67万
市值:29.74亿
市盈率:110.39
高:24.88
开:24.60
低:23.74
收:24.87
52周最高:31.77
52周最低:15.10
股本:1.25亿
流通股本:1.11亿
量比:0.89
换手率:1.38%
股息:- -
股息率:- -
每股收益(TTM):0.2154
每股收益(LYR):-0.1269
净资产收益率:15.86%
总资产收益率:5.09%
市净率:13.48
市盈率(LYR):-187.45

数据加载中...

2026/08/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/17

重要事件披露

Form 8-K - Current report
2026/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/09

重要事件披露

Form 8-K - Current report
2026/05/12

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities